Skip to main content
An official website of the United States government

News

Cover of the Jounal of the National Cancer Institute Monograph, 2022, Number 60..
A JNCI monograph on Engaging Older Adults in Cancer Clinical Trials Conducted in the National Cancer Institute Clinical Trials Network is available now. The articles, developed through working groups formed for an NCI… Learn more
POSTED: 12/21/2022
Doctor viewing mammography image on screen.
This month’s Research Highlights focuses on provider and patient beliefs about mammogram screening frequency, and separately, provider barriers to engaging in shared decision-making with high-risk patients about the use of… Learn more
POSTED: 11/28/2022
The National Cancer Institute Division of Cancer Prevention has released three Funding Opportunity Announcements to accept applications to create the Cancer Screening Research Network (CSRN). The CSRN will conduct rigorous… Learn more
POSTED: 11/21/2022
An infographic detailing CASCADE cervical cancer prevention.
Cervical cancer can be prevented by HPV vaccination and by screening for and treating precancerous lesions. Yet, millions of women globally remain at high-risk for developing cervical cancer. This is especially true for… Learn more
POSTED: 11/14/2022
AUTHOR: Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Image of breast cancer tumor in microenvironment.
This issue of Research Highlights focuses on how cells progress to become breast cancer, and separately, how breast cancer may spread. Understanding these transitional moments can help researchers keep invasive cancer from… Learn more
POSTED: 10/24/2022
A woman wearing headphones taking a hearing test.
More than half of cancer survivors who were treated with chemotherapy for the four most common types of cancer experienced clinically significant hearing loss and tinnitus after treatment, according to new research.
Learn more
POSTED: 9/27/2022
AUTHOR: Susan Jenks
As we embark on year 4 of ULACNet, this issue highlights successes & opportunities, considers how we respond to the community voice in study recruitment, discusses community participation in ULACNet-201 trial recruitment… Learn more
POSTED: 9/23/2022
An image of lab technician placing a test tube in a rack.
Recruitment has begun for a clinical study that investigators hope will move “liquid biopsy” technology closer to its still-distant goal: a single blood test for the early detection of cancer. Collectively known as multi-… Learn more
POSTED: 9/15/2022
AUTHOR: Susan Jenks
An image of various cruciferous vegetables.
Research Highlights are a new type of blog for Cancer Prevention Science, where recent publications are highlighted rather than a traditional news story.

This month’s blog post highlights how a cruciferous… Learn more
POSTED: 8/24/2022
Cover image of Cancer Care for The Whole Patient report.
In 2012, Patricia Ganz, M.D., saw a 39-year-old cancer survivor for a consultation who had a long-term history of anxiety during medical visits. The woman had been diagnosed with Hodgkin lymphoma when she was 23 years old.… Learn more
POSTED: 8/10/2022
AUTHOR: Jack J. Lee, Ph.D.
An example of a nonendometrioid cancer.
Unlike many other cancers, the incidence and death rates for uterine cancer are rising. Rates of new uterine cancer cases have risen 0.6% per year from 2010-2019, and death rates have risen an average of 1.7% per year for… Learn more
POSTED: 6/28/2022
AUTHOR: Jack J. Lee, Ph.D.
A gloved hand lifting a test tube of a blood sample from a rack.

National Cancer Institute prevention chief discusses steps toward largest U.S. cancer screening trial ever
POSTED: 6/22/2022
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) hosted a two-day virtual meeting to discuss aspirin and NSAIDs in cancer prevention and treatment.

The workshop was catalyzed by the… Learn more
POSTED: 6/15/2022
Established Risk Factors for Developing Female Breast Cancer
In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors. All women do not carry the same risk for the same type… Learn more
POSTED: 5/6/2022
In this issue, we feature: ULACNet Initiative to Enhance Community Dialogue, Community outreach strategies for recruitment in ULACNet-101 in Puerto Rico, Accrual initiated in Peru for ULACNet-301, an Investigator Spotlight… Learn more
POSTED: 4/28/2022
Illustration of biomarkers that are released by cancer cells or induced by their presence.

One of the exciting areas of cancer prevention research is the development of noninvasive tests that may have the potential to easily and accurately determine whether and where in the body a person has early-stage… Learn more
POSTED: 4/21/2022
Precision cancer screening and prevention strategies: population risk, biological risk, modality, delivery
Overall, cancer death rates in the United States have been declining about 2% per year, current SEER data from 2014 through 2018 show. However, these improvements have not been experienced equally by everyone, which is one… Learn more
POSTED: 4/18/2022
AUTHOR: Jack J. Lee, Ph.D.
Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET… Learn more
POSTED: 4/11/2022
AACR Annual Meeting 2022
April 8-13, 2022 DCP/PREVENT-funded Project Presentations Session OPO.IM01.01 - Tumor Immunobiology 5631 - Immunomodulatory activity of sulindac plus erlotinib for colon cancer prevention in familial adenomatous polyposis Presenter/Authors Chakrapani Tripathi, Roderick H. Dashwood. Texas A&M… Learn more
POSTED: 4/1/2022
A group of women from diverse backgrounds.
Philadelphia, March 25, 2022 — The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), is more than halfway to its recruiting goal of 128,905 participants with more than 20% of participants in the United States being… Learn more
POSTED: 3/25/2022
An illustration displaying signal amplification.
Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat… Learn more
POSTED: 2/9/2022
AUTHOR: Jack J. Lee, Ph.D.
Illustration showing progression from normal liver to nonalcoholic steatohepatitis.
While new cases of most cancer types have dropped over the past decade, cases of the most common type of liver cancer, hepatocellular carcinoma (HCC), are on the rise. Until recently, the main cause of HCC was hepatitis C… Learn more
POSTED: 2/4/2022
Partial screen grab of the ULACNet Zoom meeting showing a grid 9 participants.
This issue recognizes January as Cervical Cancer Awareness Month by presenting four articles entitled, "ULACNet Annual Meeting: A Global Network Together in One (Zoom) Room", "Perseverance Through the COVID… Learn more
POSTED: 1/28/2022
Photo of a health insurance statement.
Many people being treated for advanced cancer experience serious financial problems related to the cost of their care, even if they have health insurance, according to a new study.
POSTED: 1/26/2022
The Division of Cancer Prevention (DCP) of the National Cancer Institute (NCI) hosted a virtual workshop to obtain information relevant to the potential creation of a new NCI-funded cancer screening clinical trials network… Learn more
POSTED: 1/25/2022